What's new

Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 9, Status: Authorised

Mar 5, 2025 - 16:51
 0
Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, ind...

Next Article

Human medicines European public assessment report (EPAR): Enerzair Breezhaler, i...

Related Posts

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2025, 10:00 (CEST) to 29 April 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Big data

Big data

Feb 17, 2025  0